Forimtamig
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Forimtamig, covering 2025-07-14 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM) [Phase 1]